ABSTRACT
The coronavirus disease 2019 crisis is creating a shortage of personal protective equipment (PPE), most critically, N95 respirators for healthcare personnel. Our group was interested in the feasibility of ozone disinfection of N95 respirators as an alternative for healthcare professionals and organizations that might not have access to other disinfection devices. We tested the effectiveness of ozone on killing Pseudomonas aeruginosa (PsA) on three different N95 respirators: 3M 1860, 3M 1870, and 3M 8000. We used an ozone chamber that consisted of: an airtight chamber, an ozone generator, an ozone destruct unit, and an ozone UV analyzer. The chamber was capable of concentrating ozone up to 500 parts per million (ppm) from ambient air, creating an airtight seal, and precisely measuring ozone levels within the chamber. Exposure to ozone at 400 ppm with 80% humidity for two hours effectively killed bacteria on N95 respirators, types 1860, 1870, and 8000. There were no significant changes in filtration efficiency of the 1860 and 1870 type respirators for up to ten cycles of ozone exposure at similar conditions. There was no change in fit observed in the 1870 type respirator after ozone exposure. There was no significant change in the strap integrity of the 1870 type respirator after ozone exposure. Tests for filtration efficiency were not performed on the 8000 type respirator. Tests for fit or strap integrity were not performed on the 8000 or 1860 type respirators. This study demonstrates that an ozone application achieves a high level of disinfection against PsA, a vegetative bacteria that the CDC identifies as more difficult to kill than medium sized viruses such as SARS-CoV-2 (Covid-19). Furthermore, conditions shown to kill these bacteria did not damage or degrade respirator filtration. This is the first report of successful disinfection of N95 PPE with ozone of which the authors are aware. It is also the first report, to the authors’ knowledge, to identify necessary conditions for ozone to kill organisms on N95 masks without degrading the function of N95 filters.
Competing Interest Statement
The ozone chamber used for bacterial experiments was provided to the authors by Ozone Solutions (Hull, IA). Sannel Patel is an employee of Ozone Solutions (Hull, IA).
Funding Statement
EPM was funded by NHLBI Training Grant T32HL007778. LS was funded by ATS Critical Care Unrestricted Grant 2018. Prototype ozone disinfection chamber and technical support were provided by Ozone Solutions (Hull, IA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No human subjects were involved in this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred to in this manuscripts has been disclosed in the main or supplementary text. Addition data found to be missing may be requested from the corresponding author.
